Metropolis Healthcare Ltd has reported strong financial results for the quarter and year ended March 31, 2026. The company achieved a 23.6% year-on-year revenue growth for the full fiscal year, reaching INR 1,646 crores. Driven by volume expansion, specialty test growth, and integration synergies, the company maintained an EBITDA margin of 24.4%. Metropolis also announced a strategic focus on digital expansion and a target of 27%-28% EBITDA margins over the next three years.
Financial Performance Highlights
For the fourth quarter of FY26, Metropolis Healthcare achieved INR 425 crores in group revenue, representing a 23% year-on-year increase. The full-year revenue stood at INR 1,646 crores, supported by 12% patient volume growth and 13% test volume growth. On an organic basis, the company delivered a 13.7% revenue growth, exceeding its earlier guidance of 12% to 13%.
Strategic Growth Drivers
Management attributed the strong performance to the successful integration of recent acquisitions, including Core Diagnostics, and a transition from a capital-heavy model to one focused on throughput and productivity. The center-to-lab ratio improved to 24:1, with plans to reach 35:1 over the next three years. Additionally, digital channels now contribute 25% of total revenue, serving as a key pillar for sustainable, high-margin growth.
Specialty and Wellness Focus
The company continues to see strong momentum in its specialty and wellness segments. TruHealth and specialty diagnostics collectively improved the revenue mix, with the specialty segment contributing 39% of revenue in FY26. Management is targeting a CAGR of 14% to 15% over the next three years, driven by continued volume gains, enhanced RPP (Revenue Per Patient), and strategic expansion of their 100 mini-hub network.
Future Outlook and Shareholder Returns
Looking ahead, Metropolis plans to drive margin expansion through increased operating leverage and a disciplined approach to capital expenditure. Following a bonus share issue in March 2026, the Board recommended an interim dividend of INR 1 per share, reflecting confidence in the company’s financial position and commitment to creating long-term shareholder value.
Source: BSE
